Healthcare Insider Selling: Oncomed Pharmaceuticals (NASDAQ:OMED), Biota Pharmaceuticals (NASDAQ:BOTA), Agios Pharmaceuticals (NASDAQ:AGIO), BioTime (NYSEMKT:BTX), MannKind Corporation (NASDAQ:MNKD)

Oncomed Pharmaceuticals Inc. (NASDAQ:OMED) Director Denise Pollard-Knight sold 64,561 shares of the stock in a transaction dated Tuesday, June 24th. The shares were sold at an average price of $24.08, for a total transaction of $1,554,628.88. Oncomed Pharmaceuticals Inc. (NASDAQ:OMED) net profit margin is -97.60% and weekly performance is 0.91%. On last trading day company shares ended up $23.30. Analysts mean target price for the company is $43.20. Oncomed Pharmaceuticals Inc. (NASDAQ:OMED) distance from 50-day simple moving average (SMA50) is -3.39%.

Biota Pharmaceuticals Inc. (NASDAQ:BOTA) CEO Russell H. Plumb purchased 32,031 shares of the stock on the open market in a transaction that occurred on Wednesday, June 11th. The shares were purchased at an average price of $2.99 per share, for a total transaction of $95,772.69. Following the acquisition, the chief executive officer now directly owns 127,579 shares of the company’s stock, valued at approximately $381,461. Biota Pharmaceuticals Inc. (NASDAQ:BOTA) shares advanced 4.01% in last trading session and ended the day on $2.85. BOTA gross Margin is 29.50% and its return on assets is -8.00%.Biota Pharmaceuticals Inc. (NASDAQ:BOTA) quarterly performance is -53.36%.

Agios Pharmaceuticals Inc. (NASDAQ:AGIO) Insider Scott Biller sold 2,004 shares of the company’s stock on the open market in a transaction that occurred on Friday, June 20th. The shares were sold at an average price of $50.05, for a total transaction of $100,300.20. Following the transaction, the insider now directly owns 30,000 shares of the company’s stock, valued at approximately $1,501,500. Agios Pharmaceuticals Inc. (NASDAQ:AGIO) shares moved down -0.20% in last trading session and was closed at $45.82, while trading in range of $45.32 – $47.29. Agios Pharmaceuticals Inc. (NASDAQ:AGIO) year to date (YTD) performance is 91.32%.

BioTime Inc. (NYSE:BTX) Insider William P. Phd Tew unloaded 30,000 shares of BioTime stock on the open market in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $3.07, for a total transaction of $92,100.00. Following the completion of the sale, the insider now directly owns 3,265 shares in the company, valued at approximately $10,024. BioTime, Inc. (NYSEMKT:BTX) ended the last trading day at $3.05. Company weekly volatility is calculated as 5.11% and price to cash ratio as 33.34.BioTime, Inc. (NYSEMKT:BTX) showed a negative weekly performance of -5.28%.

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) net profit margin is – and weekly performance is 2.14%. On last trading day company shares ended up $10.96. Analysts mean target price for the company is $9.06. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 32.55%.